Northwest & Ethical Investments’s Dr. Reddy's Laboratories RDY Stock Holding History

Northwest & Ethical Investments’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$854K	Buy	+61,692	New	+$859K	0.02%	325
2017 Q1	–	Sell	-84,630	Closed	-$766K	–	400
2016 Q4	$766K	Buy	84,630 +19,690	+30%	+$183K	0.05%	289
2016 Q3	$603K	Hold	64,940	–	–	0.04%	275
2016 Q2	$665K	Hold	64,940	–	–	0.05%	182
2016 Q1	$587K	Buy	64,940 +35,035	+117%	+$313K	0.04%	178
2015 Q4	$277K	Sell	29,905 -41,265	-58%	-$452K	0.02%	192
2015 Q3	$910K	Buy	71,170 +34,405	+94%	+$427K	0.07%	167
2015 Q2	$407K	Hold	36,765	–	–	0.03%	203
2015 Q1	$420K	Hold	36,765	–	–	0.03%	195
2014 Q4	$371K	Buy	36,765 +5,480	+18%	+$57.7K	0.03%	202
2014 Q3	$329K	Sell	31,285 -9,165	-23%	-$86.2K	0.02%	200
2014 Q2	$349K	Buy	40,450 +980	+2%	+$8.24K	0.02%	203
2014 Q1	$347K	Buy	39,470 +19,970	+102%	+$174K	0.02%	213
2013 Q4	$160K	Buy	+19,500	New	+$154K	0.01%	225

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $70.2B AUM 29.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Northwest & Ethical Investments's RDY Position: Q1 2026 in Review

Northwest & Ethical Investments opened a new position in Dr. Reddy's Laboratories (RDY) in Q1 2026: 61,692 shares worth $854K. The stake represents 0.02% of the portfolio and ranks #325 among its holdings. This is a return to the name: Northwest & Ethical Investments previously reported a position in RDY as recently as Q4 2016.

Northwest & Ethical Investments first reported a position in RDY in Q4 2013 and has held it in 14 quarters since. The position peaked at $910K in Q3 2015. 247 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

Northwest & Ethical Investments held 61,692 shares of Dr. Reddy's Laboratories worth $854K as of Q1 2026.
Dr. Reddy's Laboratories was a new Northwest & Ethical Investments position in Q1 2026.
Dr. Reddy's Laboratories made up 0.02% of Northwest & Ethical Investments's portfolio in Q1 2026, its #325 holding.
Northwest & Ethical Investments first reported a position in Dr. Reddy's Laboratories in Q4 2013 and has held it in 14 quarters since.
Northwest & Ethical Investments's Dr. Reddy's Laboratories position peaked at $910K in Q3 2015.
247 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on Northwest & Ethical Investments's 13F filing for Q1 2026, filed 14 May 2026.